OSUR News and Press, OraSure Technologies Inc. From 11/07/23

Q3 GAAP EPS of $0.15 ; Q3 Non-GAAP EPS of $0.27 Grew cash balance to $224.9 million as of September 30, 2023 BETHLEHEM, Pa., Nov. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care and home diagnostic ...

Weyco Group Inc. (WEYS) is expected to report for Q1 2024 Gladstone Land Corporation (LAND) is expected to report $0.16 for Q3 2023 PlayAGS Inc. (AGS) is expected to report $0.01 for Q3 2023 Ardmore Shipping Corporation (ASC) is expected to report $0.43 for Q3 2023 Sage Therapeuti...

OraSure Technologies Inc. (OSUR) is expected to report $0.07 for Q3 2023

BETHLEHEM, Pa., Oct. 23, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering third quarter 2023 financial results and certain business developments for 5:00 pm ET on Tuesday, November 7, 2023. A webcast of the confer...

2023-09-20 15:26:50 ET More on COVID-19 test makers Compare metrics for ABT to BDX, RHHBF Roche: Positive Readouts From Pipeline Roche: 2023 Should Mark The Bottom Abbott Laboratories: Buy This Fairly Valued Dividend King For Consistently Rising Income ...

2023-08-07 15:40:00 ET Summary After making a new 2023 high on Monday, the market sold off for the next four days. The best performer last week was Volatility, as investors were concerned by the Fitch downgrade. The market made another new high for 2023 on Monday. For the rest...

2023-08-06 21:57:00 ET Summary OraSure Technologies' shares surged 32.3% after exceeding analysts' forecasts and providing bullish guidance for Q3. Revenue for the quarter increased by 6.5%, driven by COVID-19 diagnostic products, but the market expected a major decline in sales. ...

2023-08-04 10:09:12 ET Gainers: Alector ( ALEC ) +22% . OraSure Technologies ( OSUR ) +21% . Amneal Pharmaceuticals ( AMRX ) +20% . iRhythm Technologies ( IRTC ) +20% . Natera ( NTRA ) +16% . Losers: Mesoblast ( MESO ) ...

2023-08-03 16:21:03 ET OraSure Technologies press release ( NASDAQ: OSUR ): Q2 Non-GAAP EPS of $0.09 beats by $0.09 . Revenue of $85.44M (+6.5% Y/Y) beats by $21.56M . For further details see: OraSure Technologies Non-GAAP EPS of $0.09 beats by $0.09, rev...

InteliSwab ® test revenue of $47.5 million in Q2 Q2 Core revenue of $37.9 million grew 4% sequentially and 3% year-over-year Q2 GAAP EPS of $(0.07); Q2 Non-GAAP EPS of $0.09 Grew cash balance to $185.9 million as o f June 30, 2023 InteliSwab ...